| P2093 | author name string | Emmanuelle J Meuillet | |
| | Christine M Howison | |
| | Iman Daryaei | |
| | Mark D Pagel | |
| | Rachael W Sirianni | |
| | Joseph E Kobes | |
| | Jordan G Bontrager | |
| P2860 | cites work | Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles | Q43258446 |
| | Controlled release tacrine delivery system for the treatment of Alzheimer's disease | Q43636119 |
| | Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size | Q44930789 |
| | In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants. | Q45392265 |
| | Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system | Q45851823 |
| | Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles | Q46577046 |
| | Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. | Q54050413 |
| | [Possibilities of palliation in pancreatic cancer]. | Q54096965 |
| | Combined effects of Ag nanoparticles and oxygen plasma treatment on PLGA morphological, chemical, and antibacterial properties. | Q54318184 |
| | Layer-by-layer polyelectrolyte-polyester hybrid microcapsules for encapsulation and delivery of hydrophobic drugs | Q57217722 |
| | Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods | Q57922188 |
| | A high pressure liquid chromatographic method for the determination of tetracyclines in blood and organs of experimental animals | Q67000499 |
| | Prognostic factors in ductal pancreatic cancer | Q74707267 |
| | [Comparison of MRI manifestations and histopathologic findings in pancreatic head carcinoma in vivo ex vivo] | Q79709487 |
| | Analysis of initial burst in PLGA microparticles | Q81406385 |
| | Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas | Q83131620 |
| | Diffusion-weighted imaging of the healthy pancreas: apparent diffusion coefficient values of the normal head, body, and tail calculated from different sets of b-values | Q84753514 |
| | Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres | Q30724923 |
| | Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. | Q31068082 |
| | Diffusion tensor MRI in rat models of invasive and well-demarcated brain tumors. | Q31113794 |
| | Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer | Q33289822 |
| | A novel method for modifying AFM probe to investigate the interaction between biomaterial polymers (chitosan-coated PLGA) and mucin film | Q33534990 |
| | Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor | Q33722849 |
| | Inhalable sustained-release formulation of glucagon: in vitro amyloidogenic and inhalation properties, and in vivo absorption and bioactivity | Q33810383 |
| | Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8 | Q33852432 |
| | An introduction to diffusion tensor image analysis | Q33855086 |
| | In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT. | Q34037704 |
| | Tumour size measurement in a mouse model using high resolution MRI. | Q34286544 |
| | Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice | Q34359125 |
| | In vivo MRI of early stage mammary cancers and the normal mouse mammary gland | Q34610711 |
| | Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer. | Q34680322 |
| | In vivo dual substrate bioluminescent imaging. | Q35581797 |
| | Magnetization transfer MRI in pancreatic cancer xenograft models. | Q35881908 |
| | Evaluation of anticancer drug-loaded nanoparticle characteristics by nondestructive methodologies | Q35999089 |
| | Front-line therapy of advanced pancreatic cancer | Q36363259 |
| | Deformable and rigid registration of MRI and microPET images for photodynamic therapy of cancer in mice. | Q36551652 |
| | Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles | Q36943309 |
| | Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging | Q37001575 |
| | Advances in early diagnosis and therapy of pancreatic cancer | Q37860735 |
| | PLGA-based nanoparticles as cancer drug delivery systems | Q38191032 |
| | Determination of the metabolites of nitrofuran antibiotics in animal tissue by high-performance liquid chromatography-tandem mass spectrometry | Q38436661 |
| | Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles | Q39209045 |
| | Diffusion-weighted imaging of the healthy pancreas: ADC values are age and gender dependent | Q39533121 |
| | Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy | Q39692668 |
| | A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles | Q39930317 |
| | Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells. | Q39961374 |
| | Subcutaneous xenotransplantation of hybrid artificial pancreas encapsulating pancreatic B cell line (MIN6): functional and histological study | Q40880985 |
| | Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. | Q40890647 |
| | Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma. | Q41619756 |
| | PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. | Q41781215 |
| | Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes | Q42040527 |
| | Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier | Q42153590 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 8 | |
| P921 | main subject | nanoparticle | Q61231 |
| | pancreatic cancer | Q212961 |
| | drug delivery | Q1392806 |
| P304 | page(s) | 1158-1166 | |
| P577 | publication date | 2016-02-26 | |
| P1433 | published in | Pancreas | Q15762014 |
| P1476 | title | Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor | |
| P478 | volume | 45 | |